CDNA cloning and characterization of the third isoform of human peroxin Pex11p

Biochemical and Biophysical Research Communications

Volumn 300, Issue 4, 2003, Pages 819-823

  Tanaka, Atsushi ^a   Okumoto, Kanji ^a   Fujiki, Yukio ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CLOFIBRATE; COMPLEMENTARY DNA; ISOPROTEIN; MEMBRANE PROTEIN; PEROXIN; PEROXISOME PROLIFERATOR; PEROXISOME TARGETING SIGNAL TYPE 1 PROTEIN; PEX11P PROTEIN; PROTEIN DERIVATIVE; RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHINESE HAMSTER; CHROMOSOME 19; CONTROLLED STUDY; CYTOSOL; FIBROBLAST; GENETIC CODE; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OVARY CELL; PEROXISOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CRICETINAE; CRICETULUS GRISEUS; EUKARYOTA;

EID: 0037462961     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02936-4     Document Type: Article

References (24)

1. Lazarow P.B., Fujiki Y. Biogenesis of peroxisomes. Annu. Rev. Cell Biol. 1:1985;489-530.
2. Distel B., Erdmann R., Gould S.J., Blobel G., Crane D.I., Cregg J.M., Dodt G., Fujiki Y., Goodman J.M., Just W.W., Kiel J.A.K.W., Kunau W.-H., Lazarow P.B., Mannaerts G.P., Moser H., Osumi T., Rachubinski R.A., Roscher A., Subramani S., Tabak H.F., Tsukamoto T., Valle D., van der Klei I., van Veldhoven P.P., Veenhuis M. A unified nomenclature for peroxisome biogenesis factors. J. Cell Biol. 135:1996;1-3.
3. Fujiki Y. Peroxisome biogenesis and peroxisome biogenesis disorders. FEBS Lett. 476:2000;42-46.
4. Purdue P.E., Lazarow P.B. Peroxisome biogenesis. Anuu. Rev. Cell Dev. Biol. 17:2001;701-752.
5. Ghaedi K., Honsho M., Shimozawa N., Suzuki Y., Kondo N., Fujiki Y. PEX3 is the causal gene responsible for peroxisome membrane assembly-defective Zellweger syndrome of complementation group G. Am. J. Hum. Genet. 67:2000;976-981.
6. Matsumoto N., Tamura S., Moser A., Moser H.W., Braverman N., Suzuki Y., Shimozawa N., Kondo N., Fujiki Y. The peroxin Pex6p gene is impaired in peroxisome biogenesis disorders of complementation group6. J. Hum. Genet. 46:2001;273-277.
7. Gould S.J., Valle D. Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet. 16:2000;340-345.
8. Abe I., Fujiki Y. cDNA cloning and characterization of a constitutively expressed isoform of the human peroxin Pex11p. Biochem. Biophys. Res. Commun. 252:1998;529-533.
9. Fujiki Y., Rachubinski R.A., Lazarow P.B. Synthesis of a major integral membrane polypeptide of rat liver peroxisomes on free polysomes. Proc. Natl. Acad. Sci. USA. 81:1984;7127-7131.
10. Abe I., Okumoto K., Tamura S., Fujiki Y. Clofibrate-inducible, 28-kDa peroxisomal integral membrane protein is encoded by PEX11. FEBS Lett. 431:1998;468-472.
11. Passreiter M., Anton M., Lay D., Frank R., Harter C., Wieland F.T., Gorgas K., Just W.W. Peroxisome biogenesis: involvement of ARF and coatomer. J. Cell Biol. 141:1998;373-383.
12. Schrader M., Reuber B.E., Morrell J.C., Jimenez-Sanchez G., Obie C., Stroh T.A., Valle D., Schroer T.A., Gould S.J. Expression of PEX11. β mediates peroxisome proliferation in the absence of extracellular stimuli J. Biol. Chem. 273:1998;29607-29614.
13. Lazarow P.B., de Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes: enhancement by clofibrate, a hypolipidemic drug. Proc. Natl. Acad. Sci. USA. 73:1976;2043-2046.
14. Rachubinski R.A., Fujiki Y., Mortensen R.M., Lazarow P.B. Acyl-CoA oxidase and hydratase-dehydrogenase, two enzymes of the peroxisomal. β -oxidation system, are synthesized on free polysomes of clofibrate-treated rat liver J. Cell Biol. 99:1984;2241-2246.
15. Li X., Baumgart E., Morrell J.C., Jimenez-Sanchez G., Valle D., Gould S.J. PEX11. β deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function Mol. Cell. Biol. 22:2002;4358-4365.
16. Mukai S., Ghaedi K., Fujiki Y. Intracellular localization, function, and dysfunction of the peroxisome-targeting signal type 2 receptor, Pex7p, in mammalian cells. J. Biol. Chem. 277:2002;9548-9561.
17. Shoji H., Tsuchida K., Kishi H., Yamakawa N., Matsuzaki T., Liu Z., Nakamura T., Sugino H. Identification and characterization of a PDZ protein that interacts with activin type II receptors. J. Biol. Chem. 275:2000;5485-5492.
18. Okumoto K., Fujiki Y. PEX12 encodes an integral membrane protein of peroxisomes. Nature Genet. 17:1997;265-266.
19. Okumoto K., Abe I., Fujiki Y. Molecular anatomy of the peroxin Pex12p: RING finger domain is essential for the Pex12p function and interacts with the peroxisome targeting signal type 1-receptor Pex5p and a RING peroxin, Pex10p. J. Biol. Chem. 275:2000;25700-25710.
20. Otera H., Tateishi K., Okumoto K., Ikoma Y., Matsuda E., Nishimura M., Tsukamoto T., Osumi T., Ohashi K., Higuchi O., Fujiki Y. Peroxisome targeting signal type 1 (PTS1) receptor is involved in import of both PTS1 and PTS2: Studies with PEX5-defective CHO cell mutants. Mol. Cell. Biol. 18:1998;388-399.
21. Motley A., Hettema E., Distel B., Tabak H. Differential protein import deficiencies in human peroxisome assembly disorders. J. Cell Biol. 125:1994;755-767.
22. Okumoto K., Shimozawa N., Kawai A., Tamura S., Tsukamoto T., Osumi T., Moser H., Wanders R.J.A., Suzuki Y., Kondo N., Fujiki Y. PEX12 the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of Pex12p. Mol. Cell. Biol. 18:1998;4324-4336.
23. Hess R., Staubli W., Reiss W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxyisobutyrate in the rat. Nature. 208:1965;856-858.
24. Li X., Gould S.J. PEX11 promotes peroxisome division independently of peroxisome metabolism. J. Cell Biol. 156:2002;643-651.